Cellular Biomedicine Group Announces Appointment of New Member to the Board of Directors
SHANGHAI, China and CUPERTINO, Calif., July 12, 2016 (GLOBE NEWSWIRE) -- Cellular Biomedicine Group Inc. (NASDAQ:CBMG) (“CBMG” or the “Company”), a clinical-stage biomedicine firm engaged in the development of effective stem cell therapies for degenerative …